Multimeric Biotherapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Powerful FortiVac vaccine platform technology for CD8+ T cells against cancer and viruses. Seeking to license the technology or find an investor to help move FortiVac into the clinic. The lead indication is human papillomavirus (HPV)-associated cancer esp. cervical cancer in the field of Women's health.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}